MPH Health Care AG

XETRA 93M1.DE

MPH Health Care AG Price to Sales Ratio (P/S) on January 14, 2025: 13.04

MPH Health Care AG Price to Sales Ratio (P/S) is 13.04 on January 14, 2025, a 38.05% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

MPH Health Care AG 52-week high Price to Sales Ratio (P/S) is 20.41 on June 04, 2024, which is 56.55% above the current Price to Sales Ratio (P/S).
MPH Health Care AG 52-week low Price to Sales Ratio (P/S) is 9.29 on January 16, 2024, which is -28.71% below the current Price to Sales Ratio (P/S).
MPH Health Care AG average Price to Sales Ratio (P/S) for the last 52 weeks is 13.65.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

XETRA: 93M1.DE

MPH Health Care AG

CEO	Mr. Patrick Brenske
IPO Date	May 16, 2011
Location	Germany
Headquarters	GrUenauer Strasse 5
Employees	2
Sector	Health Care
Industries Pharmaceuticals

Description

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.

Key trends

Past 5 years